Skip to content

Kohl Al-Ethmed in treatment of inflammation of the eyelid.

A Clinical trial about comparison of novel treatment with Kohl Al-Ethmed and conventional Antibiotic therapy on patients with Blepharitis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201208017219N4
Enrollment
32
Registered
2016-02-12
Start date
2013-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blepharitis. blepharoconjunctivitis

Interventions

Intervention 1: kohl Al-Ethmed which was taken from the Saudi Arabia`s mountain and produced in powder form inside Dan kohl in the Faculty of Pharmacy, Kerman University of Medical Science. Polished
Treatment - Drugs
Placebo
kohl Al-Ethmed which was taken from the Saudi Arabia`s mountain and produced in powder form inside Dan kohl in the Faculty of Pharmacy, Kerman University of Medical Science. Polished in the eyelids
The usual treatment in the other eye is taking erythromycin ointment in the eyelids margin every night once a month

Sponsors

Vice chancellor for research, Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: anterior or posterior blepharitis in one or both eyes, recurrent chalazion. Exclusion criteria: allergic blepharitis or conjunctival inflammatory disease, and the other anterior segment diseases of the eyes.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Chalazion. Timepoint: Before Intervention , one month and two months after intervention. Method of measurement: Clinical examination with Slit lamp.;Blepharitis. Timepoint: before intervention, one month and two months after intervention. Method of measurement: Clinical examination with Slit Lamp.

Secondary

MeasureTime frame
Eyelash loss. Timepoint: before intervention, one month and two months after intervention. Method of measurement: Clinical examination with Slit Lamp.;Keratitis. Timepoint: Before Intervention , one month and two months after intervention. Method of measurement: Clinical examination with Slit Lamp.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Karbasi Esmat

Kerman University of Medical Sciences

sh_karbassi@yahoo.com+98 34 1211 5786

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026